Web Stats Provided By Google Analytics

Friday, March 28, 2014

Theradiag unveils a new automated solution at the International...

... subsidiary Prestizia, Theradiag is developing new biomarkers based on microRNAs for the diagnosis and monitoring of HIV/AIDS and rectal cancer. Theradiag is thus participating in the development of "customized treatment", which favors the ...

http://ift.tt/1o6K2ma
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)